Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches

Effective treatment choices to the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are limited because of the absence of effective target-based therapeutics. The main object of the current research was to estimate the antiviral activity of cannabinoids (CBDs) against the human coronavir...

Descripción completa

Detalles Bibliográficos
Autores principales: Raj, Vinit, Park, Jae Gyu, Cho, Kiu-Hyung, Choi, Pilju, Kim, Taejung, Ham, Jungyeob, Lee, Jintae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836687/
https://www.ncbi.nlm.nih.gov/pubmed/33290767
http://dx.doi.org/10.1016/j.ijbiomac.2020.12.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836687/
https://www.ncbi.nlm.nih.gov/pubmed/33290767
http://dx.doi.org/10.1016/j.ijbiomac.2020.12.020

Ejemplares similares